Open access
Open access
Powered by Google Translator Translator

Covid-19

Cohort study: Early initiation of prophylactic anticoagulation linked to reduced mortality in patients admitted to hospital with Covid-19

15 Feb, 2021 | 01:18h | UTC

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study – The BMJ

Commentaries: Preventive blood thinning drugs could reduce COVID hospital deaths – London School of Hygiene & Tropical Medicine AND Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients – The BMJ AND Expert reaction to a study looking at prophylactic anticoagulants as a treatment for hospitalised patients with COVID-19 – Science Media Centre AND

 

Commentary on Twitter

 

Take whatever COVID vaccine you can get. All of them stop death and hospitalization

15 Feb, 2021 | 01:17h | UTC

Take whatever COVID vaccine you can get. All of them stop death and hospitalization – USA Today

“All seven COVID-19 vaccines that have completed large efficacy trials — Pfizer, Moderna, Johnson & Johnson, Novavax, AstraZeneca, Sputnik V and Sinovac — appear to be 100% effective for serious complications. Not one vaccinated person has gotten sick enough to require hospitalization. Not a single vaccinated person has died of COVID-19.”

 

Small RCT: No effect from Zinc and Vitamin C supplementation among ambulatory patients with SARS-CoV-2 infection

15 Feb, 2021 | 01:20h | UTC

Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial – JAMA Network Open

Commentaries: Vitamin C, zinc don’t lessen Covid-19 symptoms, study finds – CNN AND Supplements for the Treatment of Mild COVID-19—Challenging Health Beliefs With Science From A to Z – JAMA Network Open AND Zinc, vitamin C show no effect for COVID-19 in small study – CIDRAP AND Expert reaction to a study looking at prophylactic anticoagulants as a treatment for hospitalised patients with COVID-19 – Science Media Centre

 

Commentary on Twitter

 

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

15 Feb, 2021 | 01:14h | UTC

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment – The Lancet

Commentary: COVID vaccination potential will not be achieved without increased production, affordable pricing, global availability – The Lancet

 

Commentaries on Twitter

 

Limited transmission of COVID-19 from open schools but teachers were affected: Swedish study

15 Feb, 2021 | 01:11h | UTC

Limited transmission of COVID-19 from open schools but teachers were affected: Swedish study – Uppsala University

Original Study: The effects of school closures on SARS-CoV-2 among parents and teachers – Proceedings of the National Academy of Sciences

 

Commentary on Twitter

 

Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US

15 Feb, 2021 | 01:13h | UTC

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 – JAMA

Author interview: COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions – JAMA

 

Commentary on Twitter

 

CDC says it’s safe to reopen schools — with proper precautions

15 Feb, 2021 | 01:09h | UTC

CDC says it’s safe to reopen schools — with proper precautions – Vox

See also: CDC Offers Clearest Guidance Yet For Reopening Schools – NPR

Guideline: Schools and Child Care Programs​ – Centers for Disease Control and Prevention

 

[Preprint] Covid-19 vaccination associated with reduced viral load, may reduce transmission

15 Feb, 2021 | 01:07h | UTC

Decreased SARS-CoV-2 viral load following vaccination – medRxiv

Commentary: COVID-19 vaccination associated with 3- to 5-fold reduction in viral load – News Medical

 

Increase aerosol transmission of Covid-19 with increased age and obesity

15 Feb, 2021 | 01:03h | UTC

Exhaled aerosol increases with COVID-19 infection, age, and obesity – Proceedings of the National Academy of Sciences

Commentary: Older, heavier adults possible ‘superspreaders’ of COVID-19, study finds – UPI AND Researchers unravel what makes someone a COVID-19 super-spreader – Tulane University

 

France’s health authority recommends single vaccine shot for people who have had COVID-19

15 Feb, 2021 | 01:02h | UTC

France’s health authority recommends single vaccine shot for people who have had COVID-19 – Euronews

See also: Covid: France says just one jab needed for previously infected – BBC

Related: Covid-19: People who have had infection might only need one dose of mRNA vaccine – The BMJ AND You’ve had COVID: maybe one dose of vaccine is enough, studies suggest – MedicalXpress

 

RCT: Tocilizumab reduces deaths in patients hospitalized with COVID-19

12 Feb, 2021 | 02:25h | UTC

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial – medRxiv

News release: Tocilizumab reduces deaths in patients hospitalised with COVID-19 – University of Oxford

Commentary: Tocilizumab cuts death rate in severe COVID-19, study finds – CIDRAP

 

Commentary on Twitter

 

Study: New B.1.1.7 variant does not result in more severe disease in children compared to the original strain

12 Feb, 2021 | 02:23h | UTC

Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people – The Lancet Child & Adolescent Health

 

Commentary on Twitter

 

Podcast: Does vaccination mean the end of masking and social distancing?

12 Feb, 2021 | 02:22h | UTC

Does Vaccination Mean the End of Masking and Social Distancing? – New England Journal of Medicine

 

Fully vaccinated people can skip Covid quarantines, CDC says

12 Feb, 2021 | 02:21h | UTC

Fully vaccinated people can skip Covid quarantines, CDC says – CNN

 

Video (6 min): A visual guide to the new coronavirus variants

12 Feb, 2021 | 02:20h | UTC

A Visual Guide to the New Coronavirus Variants – Scientific American

 

Opinion: It’s time to consider vaccine mandates in high-risk settings

12 Feb, 2021 | 02:19h | UTC

It’s Time to Consider Vaccine Mandates in High-Risk Settings – Scientific American

 

Commentary on Twitter

 

[Preprint] Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19

12 Feb, 2021 | 02:14h | UTC

Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19 – medRxiv

Commentary: Covid linked to risk of mental illness and brain disorder, study suggests – The Guardian

 

Perspective: Mandating COVID-19 Vaccines—Ethical and Legal Considerations

12 Feb, 2021 | 02:18h | UTC

Mandating COVID-19 Vaccines – JAMA

 

Commentary on Twitter

 

CDC Analysis: Effectiveness of mask wearing to control community spread of SARS-CoV-2

11 Feb, 2021 | 02:22h | UTC

Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2 – JAMA

Author interview: Mask Wearing for COVID-19 Prevention—Summary of CDC Data

 

 

CDC Guidance: Improve the fit and filtration of your mask to reduce the spread of COVID-19

11 Feb, 2021 | 02:21h | UTC

Improve the Fit and Filtration of Your Mask to Reduce the Spread of COVID-19 – Centers for Diseases Control and Prevention

 

Case report: Severe reinfection with South African SARS-CoV-2 variant

11 Feb, 2021 | 02:17h | UTC

Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report – Clinical Infectious Diseases

 

Commentary on Twitter

 

Small RCT: Inhaled budesonide reduces the need for hospitalization in COVID-19 patients

11 Feb, 2021 | 02:18h | UTC

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial – medRxiv

Commentaries: Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests – University of Oxford AND Expert reaction to preprint on an RCT of inhaled budesonide in the treatment of early COVID-19 – Science Media Centre

 

WHO experts recommend AstraZeneca COVID vaccine across all ages and countries

11 Feb, 2021 | 02:20h | UTC

WHO Report: Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca – World Health Organization

Commentaries: WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout – Health Policy Watch AND WHO backs use of Oxford/AstraZeneca Covid vaccine for adults of all ages – The Guardian AND Covid: WHO backs Oxford vaccine ‘even if variants present’ – BBC AND Expert reaction to WHO recommending use of the Oxford/AstraZeneca COVID-19 vaccine, including in over 65s – Science Media Centre AND Up Against Mutants, WHO Says AstraZeneca Vaccine Is Still A Good Bet – NPR

 

ACP: Update on Remdesivir use for hospitalized COVID-19 patients

11 Feb, 2021 | 02:15h | UTC

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians – Annals of Internal Medicine

News Release: Rapid, Living Practice Points from ACP: Update on remdesivir use for hospitalized COVID-19 patients – American College of Physicians

 

Perspective: Leave your antibodies alone

11 Feb, 2021 | 02:12h | UTC

Leave Your Antibodies Alone – The Atlantic

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.